SGLT2 inhibitor empagliflozin promotes revascularization in diabetic mouse hindlimb ischemia by inhibiting ferroptosis
Jingxuan Han, Lailiu Luo, Yi‐Cheng Wang, Makoto Miyagishi, Vivi Kasim, Shourong Wu
Topics & Concepts
EmpagliflozinSkeletal muscleC2C12MedicineInternal medicineEndocrinologyHindlimbPharmacologyDiabetes mellitusType 2 diabetesMyogenesisDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerChronic Kidney Disease and Diabetes